Given that existing therapies for intermittent claudication are not appropriate for all patients, researchers are working to develop new therapies focused on improving patients’ ability to compensate for a vascular occlusion by expanding collateral artery pathways.
By Steven J. Miller, PhD; A. George Akingba, MD, PhD; and Joseph L. Unthank, PhD




